Ad is loading...
CGC
Price
$3.73
Change
-$0.01 (-0.27%)
Updated
Nov 15 closing price
81 days until earnings call
CYTH
Price
$0.70
Change
+$0.09 (+14.75%)
Updated
Nov 15 closing price
One day until earnings call
Ad is loading...

CGC vs CYTH

Header iconCGC vs CYTH Comparison
Open Charts CGC vs CYTHBanner chart's image
Canopy Growth
Price$3.73
Change-$0.01 (-0.27%)
Volume$4.12M
CapitalizationN/A
Cyclo Therapeutics
Price$0.70
Change+$0.09 (+14.75%)
Volume$27.19K
CapitalizationN/A
CGC vs CYTH Comparison Chart
Loading...
CGC
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
CYTH
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
VS
CGC vs. CYTH commentary
Nov 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CGC is a Sell and CYTH is a Sell.

COMPARISON
Comparison
Nov 18, 2024
Stock price -- (CGC: $3.73 vs. CYTH: $0.70)
Brand notoriety: CGC: Notable vs. CYTH: Not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: CGC: 73% vs. CYTH: 85%
Market capitalization -- CGC: $784.64M vs. CYTH: $39.05M
CGC [@Pharmaceuticals: Other] is valued at $784.64M. CYTH’s [@Pharmaceuticals: Other] market capitalization is $39.05M. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $77.48B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $3.45B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CGC’s FA Score shows that 0 FA rating(s) are green whileCYTH’s FA Score has 0 green FA rating(s).

  • CGC’s FA Score: 0 green, 5 red.
  • CYTH’s FA Score: 0 green, 5 red.
According to our system of comparison, both CGC and CYTH are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CGC’s TA Score shows that 3 TA indicator(s) are bullish while CYTH’s TA Score has 3 bullish TA indicator(s).

  • CGC’s TA Score: 3 bullish, 7 bearish.
  • CYTH’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, CYTH is a better buy in the short-term than CGC.

Price Growth

CGC (@Pharmaceuticals: Other) experienced а -12.03% price change this week, while CYTH (@Pharmaceuticals: Other) price change was -5.41% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was -5.07%. For the same industry, the average monthly price growth was -7.87%, and the average quarterly price growth was -11.90%.

Reported Earning Dates

CGC is expected to report earnings on Feb 06, 2025.

CYTH is expected to report earnings on Mar 17, 2025.

Industries' Descriptions

@Pharmaceuticals: Other (-5.07% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CGC($785M) has a higher market cap than CYTH($39.1M). CGC YTD gains are higher at: -27.006 vs. CYTH (-56.038). CYTH has higher annual earnings (EBITDA): -20.03M vs. CGC (-1.02B). CGC has more cash in the bank: 186M vs. CYTH (9.25M). CYTH has less debt than CGC: CYTH (1.03M) vs CGC (693M). CGC has higher revenues than CYTH: CGC (362M) vs CYTH (1.08M).
CGCCYTHCGC / CYTH
Capitalization785M39.1M2,008%
EBITDA-1.02B-20.03M5,104%
Gain YTD-27.006-56.03848%
P/E RatioN/AN/A-
Revenue362M1.08M33,643%
Total Cash186M9.25M2,011%
Total Debt693M1.03M67,086%
FUNDAMENTALS RATINGS
CGC vs CYTH: Fundamental Ratings
CGC
CYTH
OUTLOOK RATING
1..100
8153
VALUATION
overvalued / fair valued / undervalued
1..100
94
Overvalued
88
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
97100
PRICE GROWTH RATING
1..100
9191
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

CYTH's Valuation (88) in the null industry is in the same range as CGC (94) in the Agricultural Commodities Or Milling industry. This means that CYTH’s stock grew similarly to CGC’s over the last 12 months.

CYTH's Profit vs Risk Rating (100) in the null industry is in the same range as CGC (100) in the Agricultural Commodities Or Milling industry. This means that CYTH’s stock grew similarly to CGC’s over the last 12 months.

CGC's SMR Rating (97) in the Agricultural Commodities Or Milling industry is in the same range as CYTH (100) in the null industry. This means that CGC’s stock grew similarly to CYTH’s over the last 12 months.

CGC's Price Growth Rating (91) in the Agricultural Commodities Or Milling industry is in the same range as CYTH (91) in the null industry. This means that CGC’s stock grew similarly to CYTH’s over the last 12 months.

CGC's P/E Growth Rating (100) in the Agricultural Commodities Or Milling industry is in the same range as CYTH (100) in the null industry. This means that CGC’s stock grew similarly to CYTH’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CGCCYTH
RSI
ODDS (%)
Bearish Trend 3 days ago
89%
N/A
Stochastic
ODDS (%)
Bullish Trend 3 days ago
72%
Bullish Trend 3 days ago
85%
Momentum
ODDS (%)
Bearish Trend 3 days ago
89%
Bearish Trend 3 days ago
90%
MACD
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
90%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
90%
Advances
ODDS (%)
Bullish Trend 13 days ago
80%
N/A
Declines
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 4 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
90%
Aroon
ODDS (%)
Bullish Trend 3 days ago
76%
Bullish Trend 3 days ago
84%
View a ticker or compare two or three
Ad is loading...
CGC
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
CYTH
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
UBVTX86.48-0.39
-0.45%
Undiscovered Managers Behavioral Val R3
PQDMX13.92-0.07
-0.50%
PGIM Quant Solutions Intl Dev Mkts IdxR6
OISVX16.15-0.11
-0.68%
Optimum Small-Mid Cap Value Instl
PWTYX54.89-0.51
-0.92%
UBS US Allocation P
WFOPX47.79-0.78
-1.61%
Allspring Opportunity C

CYTH and

Correlation & Price change

A.I.dvisor tells us that CYTH and ACB have been poorly correlated (+24% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CYTH and ACB's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CYTH
1D Price
Change %
CYTH100%
+13.71%
ACB - CYTH
24%
Poorly correlated
-3.23%
RDHL - CYTH
24%
Poorly correlated
+4.29%
TEVA - CYTH
22%
Poorly correlated
-1.91%
CGC - CYTH
22%
Poorly correlated
-0.27%
PTPI - CYTH
21%
Poorly correlated
-4.18%
More